By: Benzinga
UPDATE: Goldman Sachs Upgrades Thoratec Corporation to CL-Buy, Raises PT
In a report published Monday, Goldman Sachs Group upgraded its rating on Thoratec Corporation (NASDAQ: THOR ) to CL-Buy, and raised its price target from $46.00 to $48.00. Goldman Sachs noted, “We add shares of Thoratec (THOR) to the Americas Conviction Buy List with a $48 12-month price target, implying
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here